Mergers & Acquisitions ·
Matinas BioPharma Holdings, Inc. entered into a Business Combination Agreement with GH Power Inc. to merge, expected…
MTNBMatinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc. entered into a Business Combination Agreement with GH Power Inc. to merge, expected to close in Q4 2026. Under the agreement, Matinas common stockholders will receive 0.1 shares of Pubco common stock for each share held. Concurrently, the company entered into a Stock Purchase Agreement with Azurity Pharmaceuticals, Inc. for the sale of its subsidiary, Matinas Nano, for up to $21.5 million. Additionally, the company closed a $575,000 private placement of Series D Convertible Preferred Stock and a warrant inducement transaction that raised approximately $2.6 million. Matinas BioPharma Holdings, Inc. is a biopharmaceutical company focused on drug delivery technologies.